Carroll Financial Associates’s Medifast MED Stock Holding History

Carroll Financial Associates’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$41K	Sell	200 -6	-3%	-$1.24K	﹤0.01%	776
2021 Q3	$39K	Buy	206 +6	+3%	+$1.48K	﹤0.01%	811
2021 Q2	$56K	Hold	200	–	–	﹤0.01%	783
2021 Q1	$42K	Sell	200 -402	-67%	-$96.2K	﹤0.01%	806
2020 Q4	$118K	Buy	602 +159	+36%	+$28.1K	0.01%	482
2020 Q3	$73K	Sell	443 -540	-55%	-$88.9K	0.01%	550
2020 Q2	$136K	Buy	983 +365	+59%	+$33.5K	0.01%	405
2020 Q1	$38K	Buy	+618	New	+$56.3K	﹤0.01%	639

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Carroll Financial Associates's MED Position: Q4 2021 in Review

Carroll Financial Associates reduced its Medifast (MED) stake by 2.9% in Q4 2021, selling an estimated $1.24K and leaving 200 shares worth $41K. The position accounts for ﹤0.01% of the portfolio, ranked #776.

Carroll Financial Associates first reported a position in MED in Q1 2020 and has held it in 8 quarters since. The position peaked at $136K in Q2 2020. 297 funds tracked by Wall St. Rank hold MED as of Q4 2021.

Carroll Financial Associates held 200 shares of Medifast worth $41K as of Q4 2021.
Carroll Financial Associates sold 6 Medifast shares in Q4 2021, an estimated $1.24K.
Medifast made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #776 holding.
Carroll Financial Associates first reported a position in Medifast in Q1 2020 and has held it in 8 quarters since.
Carroll Financial Associates's Medifast position peaked at $136K in Q2 2020.
297 funds tracked by Wall St. Rank held Medifast as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.